EMA Withdrawn: Topotecan Eagle (topotecan hydrochloride) — Eagle Laboratories Ltd.

View source ↗

Summary

EMA has withdrawn Topotecan Eagle (topotecan hydrochloride) from the market.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Carcinoma
• Small Cell Lung Carcinoma

Drugs mentioned

• Topotecan Eagle (topotecan hydrochloride)

Snippet

Status: Withdrawn. Therapeutic area: Carcinoma;Small Cell Lung Carcinoma. MAH: Eagle Laboratories Ltd.. Decision date: 02/10/2014